Lactobacillus gasseri CP2305 is a strain of lactic acid bacteria isolated from the stool of a healthy adult. Six of its 7 trials in PubMed used heat-treated cells, which are not alive. Trial reports call such cells a paraprobiotic or a postbiotic. Trials state the amount as a count of cells; most used 10 billion a day.
Terms and sources
isolated
Sugawara et al., Microb Ecol Health Dis, 2016; Nishida et al., Nutrients, 2019.
heat-treated cells
Grown, washed with water, heated to 90 °C (194 °F) and freeze-dried. Sugawara et al., 2016. The seventh trial, in people with a diagnosis, used live cells, by the account of Nishida et al., 2019.
postbiotic
NIH ODS uses the word postbiotics for preparations of dead microorganisms; see below.
10 billion
1 × 10¹⁰ cells, as two tablets or one 200 mL drink. Tanihiro et al., 2026, state that earlier trials used this amount consistently.
Heat-treated CP2305 in the body
Heat-treated CP2305 is not a nutrient, and the body has no daily requirement for it. Its trials measure sleep questionnaires, sleep by home EEG, stress ratings and stool habits.
One trial report states that heat-treated CP2305 cannot survive in the gut or make active metabolites. Another states that the trial tablets hold no active metabolites made by live bacteria. Live CP2305 was reported to settle in the gut of 40% of people who took it.
Terms and sources
cannot survive in the gut
Tanihiro et al., Frontiers in Nutrition, 2026. All 4 authors worked at Asahi Quality and Innovations, Ltd.
Another states
Nishida et al., Nutrients, 2019.
40% of people
Nishida et al., 2019, citing earlier work. The figure is for live cells, not heat-treated ones.
NIH ODS separates probiotics from postbiotics: "Probiotics should also not be confused with postbiotics, which are preparations comprised of dead, intact, or fragmented microorganisms, with or without their metabolites, that confer a health benefit on the host." NCCIH describes probiotics as live microorganisms. NIH ODS quotes a definition from ISAPP that also calls them live. We found no text from either agency on heat-treated CP2305. Their safety sections are about probiotics as defined above; they do not mention heat-treated cells. The 2 trials listed below report no adverse events.
Terms and sources
separates probiotics from postbiotics
NIH Office of Dietary Supplements, probiotics fact sheet for health professionals. It cites the 2021 consensus statement of the International Scientific Association for Probiotics and Prebiotics.
live microorganisms
NCCIH, Probiotics: Usefulness and Safety.
ISAPP
International Scientific Association for Probiotics and Prebiotics. NIH ODS, probiotics fact sheet for health professionals.
no adverse events
Nishida 2019: 60 students over 24 weeks. Tanihiro 2026: 28 adults after one dose.
Where CP2305 comes from
For one trial, the strain was grown in a broth of glucose, casein, fish peptone and yeast extract. The cells were then filtered, washed with water, heated to 90 °C (194 °F) and freeze-dried. Another trial report gives at least 760 billion cells per gram of the dried powder. By our calculation, 10 billion cells come to about 13 mg of that powder or less.
Terms and sources
For one trial
Sugawara et al., Microb Ecol Health Dis, 2016. The broth also held a pH adjuster and an emulsifier.
heated to 90 °C (194 °F)
Sugawara et al., 2016.
at least 760 billion cells per gram
7.6 × 10¹¹ cells per gram. Fuchida et al., Toxicology Reports, 2026.
about 13 mg
10 billion ÷ 760 billion per gram = 0.013 g. Our estimate; the powder has at least that many cells per gram.
The trial tablets also hold maltose, dextrin, starch and vegetable oil. The dummy tablets replace the cell powder with dextrin. A trial drink with the cells was made at Asahi Soft Drinks Co., Ltd.
Terms and sources
maltose, dextrin, starch and vegetable oil
Nishida et al., 2019; Tanihiro et al., 2026.
Asahi Soft Drinks Co., Ltd.
Sugawara et al., 2016.
Daily amounts and the upper limit
United States
There is no US recommended daily amount for CP2305. The National Academies have not set an upper limit for CP2305.
NIH ODS notes: "The number of viable cells in a probiotic supplement is indicated by the number of colony-forming units (CFU) listed on the label." Trials of heat-treated CP2305 give a count of cells instead.
No US label in the NIH label database names CP2305. Of 867 labels that name Lactobacillus gasseri, none names CP2305 or a heat treatment in the same entry. 39 labels use the word postbiotic, and 5 name a heat-treated bacterium of another strain.
Terms and sources
No US label
NIH Dietary Supplement Label Database, 214,768 labels, including products no longer sold. Whole-word search for CP2305 in every ingredient and form entry. We counted these.
867 labels
Strains named most often are LG-36, CUL-09 and SD-5585. Most of these entries give no amount of their own.
5 name a heat-treated bacterium
Heat-treated Lactobacillus plantarum L-137 on 4 labels and a heat-treated Bifidobacterium animalis strain on 1. We counted these.
Trials of heat-treated CP2305 used tablets or a 200 mL drink. Earlier work used live CP2305, or milk fermented with it and sometimes heat-treated. The trials here did not test other Lactobacillus gasseri strains. We do not rank forms.
Terms and sources
200 mL drink
Sugawara et al., 2016: one bottle a day with 10 billion cells.
Earlier work
Described by Nishida et al., 2019, and Sugawara et al., 2016.
Heat-treated CP2305 tablets and drink, live CP2305, fermented milk and other Lactobacillus gasseri strains
Tablets: Nishida 2019 and Tanihiro 2026. Drink: Sugawara 2016. Live cells and fermented milk: earlier work described by Nishida 2019 and Sugawara 2016.
Published studies of CP2305
We found no text from NIH ODS or NCCIH that rates the evidence for CP2305. All 7 trial reports of CP2305 we found in PubMed list an author from an Asahi Group company.
Terms and sources
an Asahi Group company
Asahi Group Holdings, Ltd., or Asahi Quality and Innovations, Ltd., by PubMed affiliations. Five of these reports state that an Asahi company paid for the study. We could not read the funding sections of the other 2.
Trials in people with a diagnosis, or chosen by symptom scores or bowel habits, are not listed here.
2 studies in adults without a diagnosis: 2 found a difference.
Both listed trials used 10 billion heat-treated cells. Asahi Group Holdings paid for both. Not listed: a review that combined trials, whose trial list we could not read. Also not listed: a trial whose abstract does not state random groups or a comparison. Also not listed: trials that chose people by symptom scores or by bowel habits. Also not listed: a trial of 100 billion cells a day. Also not listed: a trial in people with a diagnosis, which used live cells. Also not listed: a review of many preparations that its authors call postbiotics.
Our one-line summary comes first. The original is on PubMed.
Show the 2 studies
Medical students preparing for a national exam took CP2305 tablets for 24 weeks; sleep scores differed from a dummy tablet.
Trial · 60 people · 24 weeks · industry-funded
Nishida et al., Nutrients, 2019
Terms and sources
Medical students
60 sixth-year medical students in Japan, 41 men and 19 women. None had a diagnosed illness or took regular medicines. The methods and results give different group splits, 29 and 31 or 31 and 29. 74 were recruited. The paper lists 7 excluded for medicines, 3 for hormonal contraceptives and 4 for active illness.
national exam
The 24 weeks ended 2 weeks before the national medical licensing exam. Students were not chosen by symptom scores.
CP2305 tablets
Two tablets once a day, with 10 billion heat-inactivated, washed and dried CP2305 cells. The authors report no adverse events.
sleep scores
Sleep questionnaire (PSQI) scores differed from the dummy tablet. By home EEG, time to the first deep-sleep stage and time awake after falling asleep were shorter. Total REM and non-REM sleep did not differ. The share of deep-sleep brain waves in the first sleep cycle was higher than with the dummy tablet. Total deep-sleep wave power did not differ.
differed
Statistically significant. Usual-tension scores, a hospital mood questionnaire, irritability and stomach discomfort ratings and saliva chromogranin A also differed. Current-tension scores rose before the exam in both groups and did not differ. Saliva cortisol did not differ. General health questionnaire totals did not differ; one of its subscales did. Weekly tiredness and sleep-trouble ratings were collected; the paper gives no result for them.
a dummy tablet
Placebo tablets made the same way, with dextrin in place of the cell powder.
industry-funded
Asahi Group Holdings, Ltd. paid for the study. One of 5 authors works at Asahi Quality & Innovations, Ltd., a related company.
Our estimate at 200 words a minute, from the words of the abstract and main text without tables and figures.
Study summary
Sixty medical students in Japan took tablets with 10 billion heat-inactivated CP2305 cells or a dummy tablet for 24 weeks. The trial ended 2 weeks before their national exam. Sleep questionnaire scores differed from the dummy tablet. By home EEG, time to deep sleep and time awake at night were shorter. Usual-tension and mood scores also differed. Current-tension scores rose in both groups before the exam and did not differ. Saliva cortisol did not differ. The authors report no adverse events. Funding: Asahi Group Holdings. One author works at Asahi Quality & Innovations, a related company.
Healthy adults took one dose of CP2305 tablets; stress ratings and some brain-wave measures differed from a dummy tablet.
Trial · 28 people · One dose, each tablet type · industry-funded
Tanihiro et al., Frontiers in Nutrition, 2026
Terms and sources
Healthy adults
28 healthy adults aged 20–44, 14 women and 14 men. The authors report no adverse events or side effects.
one dose
Each took both tablet types, one after the other, at least 3 days apart, in random order.
CP2305 tablets
Two tablets with 10 billion heat-treated CP2305 cells.
stress ratings
Measured after mental arithmetic and a listening attention task, within 60 minutes. A 0–100 mm stress scale and the tension score of a mood questionnaire differed from the dummy tablet. The other 6 mood scores did not.
some brain-wave measures
Alpha power rose more than with the dummy tablet at 4 of 8 scalp sites. It did not differ at the other 4. Beta power differed at 1 site. Pulse-interval variation (RMSSD) during the arithmetic task also differed. The authors read it as rest-and-digest nerve activity. EEG data from 23 people (22 in the dummy-tablet condition) and pulse data from 24 were analyzed.
a dummy tablet
Placebo tablets with dextrin in place of the cell powder, the same in look and taste.
industry-funded
Asahi Group Holdings, Ltd. paid for the study. All 4 authors worked at Asahi Quality and Innovations, Ltd., a group affiliate.
Our estimate at 200 words a minute, from the words of the abstract and main text without tables and figures.
Study summary
Twenty-eight healthy adults took tablets with 10 billion heat-treated CP2305 cells once and a dummy tablet once, in random order. After mental arithmetic and a listening task, stress ratings differed from the dummy tablet. So did the tension score of a mood questionnaire. Six other mood scores did not differ. Alpha brain waves rose more at 4 of 8 scalp sites. Pulse-interval variation also differed. The authors report no adverse events. Funding: Asahi Group Holdings. All 4 authors worked at its affiliate Asahi Quality and Innovations.
Not sure what to choose, or couldn’t find what you were looking for? Ask our expert
Information, not a prescription. Do not start, stop or combine supplements or medicines on your own. If you have a health condition, are pregnant or breastfeeding, take medicines, or are under 18, talk to a doctor or pharmacist first.